0.00Open0.20Pre Close0 Volume86 Open Interest20.00Strike Price0.00Turnover82.03%IV16.29%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1739Delta0.1133Gamma86.85Leverage Ratio-0.0324Theta0.0007Rho15.11Eff Leverage0.0071Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet